Delivery Order SPE2DR25D2206-SPE2DR26F9BC3
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,036.00 to AmerisourceBergen Drug Corp for the supply of Omnipaque 300 mg/ml vials (10 ml units). This firm fixed-price, competitively awarded contract was executed on October 29, 2025, with an ultimate completion date of October 30, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a continuation of the company's extensive...
- The Defense Logistics Agency awarded a $1,582.41 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Omnipaque 180 mg/mL vials (10 mL units) on August 20, 2025, with a completion date of August 21, 2025. This non-set-aside competitive award will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999.00...
- The Defense Logistics Agency awarded a $2,663.78 delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Omnipaque 300 mg/ml Pluspak 500ml, a contrast medium used in medical imaging procedures. This firm fixed-price delivery order is not set-aside and is scheduled for completion by November 10, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 8, 2025, for the supply of Omnipaque 240 mg/ml vials (10 ml units) at a ceiling value of $1,200.00. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by August 11, 2025, and will be performed at the awardee's location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting federal medical supply needs...
- The Defense Logistics Agency awarded a delivery order valued at $2,705.28 to AmerisourceBergen Drug Corp for Omnipaque 350 mg/mL Pluspak 500mL, a contrast medium used in medical imaging procedures. This firm fixed price delivery order, which became effective on October 28, 2025, with a completion date of October 29, 2025, represents a small-value transaction under AmerisourceBergen's larger contract portfolio with the agency. The product will be delivered to the company's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $1,171.00 to AmerisourceBergen Drug Corp for the supply of Omnipaque 300 mg/ml infusion bottles (100 ml units). The contract, issued on September 17, 2025, with an ultimate completion date of September 18, 2025, represents a firm fixed price delivery order with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $1,044.65 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Omnipaque 240 mg/ml vials (10 ml) on August 7, 2025, with an ultimate completion date of August 8, 2025. This delivery order is classified as non-set-aside and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a small-value transaction typical of the company's extensive portfolio of pharmaceutical product...
- The Defense Logistics Agency awarded a delivery order valued at $1,814.91 to AmerisourceBergen Drug Corp for Omnipaque 300 mg/ml Pluspak 500ml, a contrast medium used in medical imaging procedures. This non-competitive, firm fixed-price delivery order was awarded on August 14, 2025, with an ultimate completion date of August 15, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Omnipaque 350 mg/mL Pluspak 500mL, a contrast medium used in medical imaging procedures. Valued at $5,410.56 with a firm fixed price structure, this non-set-aside delivery order represents a competitive award under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate headquarters in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Omnipaque 300 mg/mL Pluspak 500mL contrast media, with a contract ceiling value of $1,141.62. This is a firm fixed-price delivery order under a non-set-aside competitive procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 7, 2025. This delivery order represents a...
- SPE2DR25D2206Indefinite Delivery Contract
- SPE2DR25D2206-SPE2DR26F9BC3Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,467.90 to supply Omnipaque 300 mg/ml in 30ml containers. The award was made on November 10, 2025, with an ultimate completion date of November 12, 2025. This is a firm fixed price delivery order with no set-aside designation, reflecting competitive award practices. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceuticals and medical supplies to support military healthcare programs globally. AmerisourceBergen's extensive contract portfolio with the Defense Logistics Agency demonstrates its role as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 11/10/25 |